Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 77.67 | 71 |
GSM780708 | Untreated after 4 days (C2_1) | 69.1648 | 69 |
GSM780709 | Untreated after 4 days (C3_1) | 55.3524 | 60 |
GSM780719 | Untreated after 4 days (C1_2) | 81.9027 | 72 |
GSM780720 | Untreated after 4 days (C2_2) | 73.1894 | 70 |
GSM780721 | Untreated after 4 days (C3_2) | 53.1196 | 56 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 68.5203 | 69 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 69.3249 | 69 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 84.9567 | 73 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 59.9698 | 64 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 75.2673 | 71 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 96.4853 | 75 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 65.1337 | 67 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 69.5337 | 69 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 67.6192 | 68 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 73.3987 | 70 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 73.4653 | 70 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 65.6764 | 67 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 90.6325 | 74 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 63.7905 | 67 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 72.0952 | 70 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 71.0927 | 69 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 73.9605 | 70 |